[ad_1] Biocon's share price lost more than 1% on Monday. The USFDA conducted a pre-inspection at the company's new solid oral dosage form manufacturing facility at Biocon Park . The inspection took …
Read More »Biocon moves closer to European approval of biosimilar trastuzumab
[ad_1] Biocon and its partner Mylan announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) had issued a positive opinion in which they recommended …
Read More »